Jackie Weiss

Jan 17, 2024 | mlo-online.com | Chris Gardner |Kara Nadeau |Jackie Weiss

A special issue of the Association for Diagnostics & Laboratory Medicine’s (formerly AACC’s) The Journal of Applied Laboratory Medicine highlights the latest research in this field that could advance care for conditions ranging from infectious diseases to inherited disorders. Sequencing cell-free DNA in blood samples has the potential to improve infectious disease evaluation and treatment, and is explored in a study published in this issue.

Dec 18, 2023 | mlo-online.com | Chris Gardner |Kara Nadeau |Jackie Weiss

Molecular diagnostics applies techniques of molecular biology to diagnose disease, as well as predict its course; select appropriate treatments; and monitor treatments’ effectiveness.1 Testing within this medical field often involves a complex workflow of many steps that are prone to variability. Different factors can influence this variability, and if they are not controlled, they could alter specimen integrity and thus lead to patient misdiagnosis.

Nov 27, 2023 | mlo-online.com | Chris Gardner |Kara Nadeau |Jackie Weiss

Revvity, Inc., announced the launch of its EONIS Q system, a CE-IVD declared platform enabling laboratories in countries that accept the CE marking to adopt molecular testing for spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) in newborns. The EONIS Q system simplifies and streamlines molecular testing for SMA and SCID with an innovative workflow, inclusive of the EONIS Q96 instrument, the EONIS SCID-SMA kit and dedicated EONIS EASI software.

Nov 20, 2023 | mlo-online.com | Chris Gardner |Kara Nadeau |Jackie Weiss

For a printable version of the December CE Story and test go HEREor to take test online goHERE. For more information, visit the Continuing Education tab.    LEARNING OBJECTIVESUpon completion of this article, the reader will be able to:   1. List the different types of bloodstream infections currently infecting patients. 2. Discuss healthcare statistics among bloodstream infections. 3. Identify fungal blood stream infections and discuss the need to rapidly identify them. 4.

Oct 18, 2023 | mlo-online.com | Kara Nadeau |Chris Gardner |Jackie Weiss

The molecular diagnostics (MDx) market is estimated to be worth $16.6B in 2023, and expected to reach $28.6B by 2028, as “Rapid progress in technologies such as next-generation sequencing, gene editing, and personalized medicine will drive increased adoption of molecular diagnostic tests.”1 To reflect the broadening availability and use of MDx testing, and a shifting focus from COVID-19 testing to other applications, the 2023 Medical Laboratory Observer (MLO) State of the Industry (SOI)...